Nuvalent, Inc., the Cambridge, Massachusetts-based biopharmaceutical company traded on the Nasdaq Global Select Market under the ticker NUVL, has been fully acquired by GlaxoSmithKline LLC, a subsidiary of GSK plc, following the successful completion of a cash tender offer and subsequent merger on July …
Veradermics, Incorporated, a Delaware-incorporated specialty dermatology company listed on the New York Stock Exchange under the ticker MANE, announced on July 15, 2026, that its Phase 2 clinical trial known as Study '207' produced positive topline results for VDPHL01, its proprietary extended-release oral minoxidil …
NRG Energy, Inc. has disclosed that its power plant generation capacity cleared in the PJM Interconnection capacity auction for the 2028–2029 delivery year, with a total of 6,839 megawatts secured at an average clearing price of $325 per MW-day. The announcement, dated July 14, …
Cintas Corporation, one of North America's leading providers of corporate identity uniforms and workplace services, disclosed its financial results for the fiscal quarter ended May 31, 2026, via a press release issued on July 15, 2026. The announcement was signed by Scott A. Garula, …
Johnson & Johnson, the diversified healthcare giant headquartered in New Brunswick, New Jersey, announced its sales and earnings results for the second quarter ended June 28, 2026, in a disclosure dated July 15, 2026. The announcement, signed by Controller Robert J. Decker, Jr. as …
Conagra Brands, Inc., the Chicago-based packaged food company behind well-known consumer brands, disclosed its fourth quarter fiscal 2026 financial results on July 15, 2026, through a press release issued the same day. The announcement represents the company's final quarterly earnings update for fiscal year …
Entegris, Inc., the Billerica, Massachusetts-based semiconductor materials and solutions company, has announced that its board of directors declared a quarterly cash dividend of $0.10 per share, according to a disclosure filed on July 15, 2026. The dividend is scheduled to be paid on August …
Axsome Therapeutics, Inc. has announced that the U.S. Food and Drug Administration has accepted for filing the company's New Drug Application for AXS-12 (reboxetine), a candidate being developed for the treatment of cataplexy in patients with narcolepsy. The announcement, made on July 15, 2026, …
The PNC Financial Services Group, Inc. announced its earnings and business results for the second quarter of 2026 on July 15, 2026, disclosing the update alongside supplementary financial information made available on the company's website. The announcement, signed by Senior Vice President and Controller …
BlackRock, Inc. disclosed its results of operations for the three and six months ended June 30, 2026, on July 15, 2026, filing a current report with U.S. securities regulators. The company simultaneously announced it would hold an investor conference call and webcast on the …